Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Pliant Therapeutics (PLRX) Return on Equity (2020 - 2025)

Pliant Therapeutics (PLRX) has disclosed Return on Equity for 6 consecutive years, with 0.77% as the latest value for Q4 2025.

  • Quarterly Return on Equity fell 13.0% to 0.77% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.77% through Dec 2025, down 13.0% year-over-year, with the annual reading at 0.61% for FY2025, 7.0% down from the prior year.
  • Return on Equity for Q4 2025 was 0.77% at Pliant Therapeutics, up from 0.83% in the prior quarter.
  • The five-year high for Return on Equity was 0.26% in Q2 2023, with the low at 0.87% in Q2 2025.
  • Average Return on Equity over 5 years is 0.5%, with a median of 0.46% recorded in 2021.
  • The sharpest move saw Return on Equity plummeted -50bps in 2021, then surged 42bps in 2023.
  • Over 5 years, Return on Equity stood at 0.46% in 2021, then rose by 18bps to 0.38% in 2022, then rose by 13bps to 0.33% in 2023, then tumbled by -96bps to 0.65% in 2024, then dropped by -19bps to 0.77% in 2025.
  • According to Business Quant data, Return on Equity over the past three periods came in at 0.77%, 0.83%, and 0.87% for Q4 2025, Q3 2025, and Q2 2025 respectively.